Who
Carrolee Barlow
Director
Company insider
Files Form 4 as: Director, Supernus Pharmaceuticals.
In numbers
- Trades disclosed
- 30
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 1
- First trade
- 27 Jun 2018
- Last trade
- 24 Feb 2026
- Last filed
- 25 Feb 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 24 Feb 2026filed 25 Feb 2026 | SUPN Supernus PharmaceuticalsPharmaceuticals | SEC FORM 4 Code A | —4,475 at $0.00 | filing |
| 24 Feb 2026filed 25 Feb 2026 | SUPN Supernus Pharmaceuticalsoption or derivative · Pharmaceuticals | SEC FORM 4 Code D | —4,475 at $0.00 | filing |
| 24 Feb 2026filed 25 Feb 2026 | SUPN Supernus Pharmaceuticalsoption or derivative · Pharmaceuticals | SEC FORM 4 Code D | —4,475 at $0.00 | filing |
| 24 Feb 2026filed 25 Feb 2026 | SUPN Supernus PharmaceuticalsPharmaceuticals | SEC FORM 4 Code A | —4,475 at $0.00 | filing |
| 18 Feb 2026filed 20 Feb 2026 | SUPN Supernus Pharmaceuticalsoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —2,989 at $0.00 | filing |
| 18 Feb 2026filed 20 Feb 2026 | SUPN Supernus Pharmaceuticalsoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —4,977 at $0.00 | filing |
| 18 Feb 2026filed 20 Feb 2026 | SUPN Supernus Pharmaceuticalsoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —2,989 at $0.00 | filing |
| 18 Feb 2026filed 20 Feb 2026 | SUPN Supernus Pharmaceuticalsoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —4,977 at $0.00 | filing |
| 22 Feb 2025filed 24 Feb 2025 | SUPN Supernus Pharmaceuticalsoption or derivative · Pharmaceuticals | SEC FORM 4 Code D | —5,369 at $0.00 | filing |
| 22 Feb 2025filed 24 Feb 2025 | SUPN Supernus PharmaceuticalsPharmaceuticals | SEC FORM 4 Code A | —5,369 at $0.00 | filing |
| 19 Feb 2025filed 21 Feb 2025 | SUPN Supernus Pharmaceuticalsoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —7,296 at $0.00 | filing |
| 19 Feb 2025filed 21 Feb 2025 | SUPN Supernus Pharmaceuticalsoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —4,475 at $0.00 | filing |
| 23 Feb 2024filed 27 Feb 2024 | SUPN Supernus Pharmaceuticalsoption or derivative · Pharmaceuticals | SEC FORM 4 Code D | —3,886 at $0.00 | filing |
| 23 Feb 2024filed 27 Feb 2024 | SUPN Supernus PharmaceuticalsPharmaceuticals | SEC FORM 4 Code A | —3,886 at $0.00 | filing |
| 22 Feb 2024filed 26 Feb 2024 | SUPN Supernus Pharmaceuticalsoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —8,252 at $0.00 | filing |
| 22 Feb 2024filed 26 Feb 2024 | SUPN Supernus Pharmaceuticalsoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —5,369 at $0.00 | filing |
| 23 Feb 2023filed 27 Feb 2023 | SUPN Supernus Pharmaceuticalsoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —6,293 at $0.00 | filing |
| 23 Feb 2023filed 27 Feb 2023 | SUPN Supernus Pharmaceuticalsoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —3,886 at $0.00 | filing |
| 22 Feb 2023filed 24 Feb 2023 | SUPN Supernus Pharmaceuticalsoption or derivative · Pharmaceuticals | SEC FORM 4 Code D | —3,882 at $0.00 | filing |
| 22 Feb 2023filed 24 Feb 2023 | SUPN Supernus PharmaceuticalsPharmaceuticals | SEC FORM 4 Code A | —3,882 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.